Skip to content
2000
Volume 19, Issue 19
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

There remains a great need to develop therapeutic agents to treat critical size defects and non-union fractures and one of the potential agents is recombinant human fibroblast growth factor 2 (FGF-2). We discuss the function of FGF-2 in bone formation, bone resorption, and downstream signaling pathways and review the role of exogenous FGF-2 in fracture healing. The importance of endogenous FGF-2 in bone formation and its potential importance in fracture healing in response to parathyroid hormone (PTH) and bone morphogenetic protein 2 (BMP2) is described. In addition we will review, FGF-2 signaling crosstalk with Wnt signaling and PTH signaling in bone formation and repair. Finally, we discuss the outstanding unresolved issues in the application of FGF-2 as therapeutic agent for bone regeneration.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612811319190002
2013-06-01
2025-04-22
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612811319190002
Loading

  • Article Type:
    Research Article
Keyword(s): Bone Homeostasis; FGF-2; Fracture Repair
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test